<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>200057</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>8676071</PubmedId>
            <Abstract>A subtractive analysis of peptides eluted from major histocompatibility complex (MHC) class I human histocompatibility leukocyte antigen (HLA)-A2.1 molecules purified from either human immunodeficiency virus type-1 (HIV-1)-infected or uninfected cells was performed using micro high-performance liquid chromatography and mass spectrometry. Three peptides unique to infected cells were identified and found to derive from a single protein, human vinculin, a structural protein not known to be involved in viral pathogenesis. Molecular and cytofluorometric analyses revealed vinculin mRNA and vinculin protein overexpression in B and T lymphocytes from HIV-1-infected individuals. Vinculin peptide-specific CTL activity was readily elicited from peripheral blood lymphocytes of the majority of HLA-A2.1+, HIV+ patients tested. Our observations suggest that atypical vinculin expression and MHC class I-mediated presentation of vinculin-derived peptides accompany HIV infection of lymphoid cells in vivo, with a resultant induction of antivinculin CTL in a significant portion of HIV+ (HLA-A2.1+) individuals.</Abstract>
            <ArticleYear>1996</ArticleYear>
            <ArticlePages>2509-16</ArticlePages>
            <ArticleTitle>Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>di Marzo Veronese</LastName>
                    <ForeName>F</ForeName>
                </Author>
                <Author>
                    <LastName>Arnott</LastName>
                    <ForeName>D</ForeName>
                </Author>
                <Author>
                    <LastName>Barnaba</LastName>
                    <ForeName>V</ForeName>
                </Author>
                <Author>
                    <LastName>Loftus</LastName>
                    <ForeName>D J</ForeName>
                </Author>
                <Author>
                    <LastName>Sakaguchi</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Thompson</LastName>
                    <ForeName>C B</ForeName>
                </Author>
                <Author>
                    <LastName>Salemi</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Mastroianni</LastName>
                    <ForeName>C</ForeName>
                </Author>
                <Author>
                    <LastName>Sette</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Shabanowitz</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Hunt</LastName>
                    <ForeName>D F</ForeName>
                </Author>
                <Author>
                    <LastName>Appella</LastName>
                    <ForeName>E</ForeName>
                </Author>
            </Authors>
            <Affiliations>Laboratory of Tumor Cell Biology, National Institutes of Health, Bethesda, Maryland 20892, USA.</Affiliations>
            <ArticleChemicalList>HLA-A2 Antigen;Peptides;Viral Proteins;Vinculin</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; B-Lymphocytes(immunology); Binding Sites; Chromatography, High Pressure Liquid; Cytotoxicity, Immunologic; Flow Cytometry; HIV Infections(immunology); HIV-1(immunology); HLA-A2 Antigen(immunology; isolation &amp; purification); Humans; Major Histocompatibility Complex; Mass Spectrometry; Molecular Sequence Data; Peptides(chemical synthesis; chemistry; immunology); Reference Values; T-Lymphocytes(immunology); T-Lymphocytes, Cytotoxic(immunology); Vinculin(biosynthesis; immunology; isolation &amp; purification); Viral Proteins(chemistry; immunology)</ArticleMeshHeadingsList>
            <Comments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/) and from the HLA Ligand Database (http://hlaligand.ouhsc.edu/)</Comments>
            <Journal>
                <Volume>183</Volume>
                <Issue>6</Issue>
                <Title>The Journal of experimental medicine</Title>
                <Issn>0022-1007</Issn>
                <MedlineTa>J Exp Med</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GLDVLTAKV</LinearSequence>
                        <StartingPosition>359</StartingPosition>
                        <EndingPosition>367</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P18206.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>20812</EpitopeId>
                <ReferenceStartingPosition>358</ReferenceStartingPosition>
                <ReferenceEndingPosition>366</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>202669</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>132.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RILGAVAKV</LinearSequence>
                        <StartingPosition>823</StartingPosition>
                        <EndingPosition>831</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P18206.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>54184</EpitopeId>
                <ReferenceStartingPosition>822</ReferenceStartingPosition>
                <ReferenceEndingPosition>830</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>202670</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>91.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

